23/07/2010 (Agence Europe) - In a press release published on 22 July, the European Medicines Agency (EMEA) says there is a positive risk-benefit outcome for the use of topical formulations of ketoprofen despite the undesirable side effect in some cases of increasing sensitivity to the light. This side effect is more frequent if the ketoprofen non-steroidal anti-inflammatory drug (NSAID) is used at the same time as cosmetics or skin cream containing octocrylene, a chemical sun-filter. The...